Xadago

Chemical Namesafinamide
Dosage FormTablet (oral; 50, 100 mg)
Drug ClassInhibitors
SystemMusculoskeletal, Nervous
CompanyUS Worldmeds
Approval Year2017

Indication

  • To treat Parkinson’s disease in conjunction with levodopa/carbidopa.
Last updated on 12/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xadago (Safinamide) Prescribing Information 2017US WorldMeds, LLC, Louisville, KY